Table of Contents: September/October 2019
Table of contents for Today’s Veterinary Practice September/October 2019 issue.
Diagnosis, Treatment, and Management of Leptospirosis in Dogs
Leptospirosis is an emerging zoonotic disease found throughout most of the United States. Leptospirosis affects many organ systems and varies in severity; clinical signs range from none or mild and self-limiting to severe with acute kidney injury, hepatopathy, and/or vasculitis. Fortunately, the prognosis for most patients is favorable with appropriate medical care.
Canine Immune-Mediated Polyarthritis: Meeting the Diagnostic and Therapeutic Challenges
Immune-mediated polyarthritis (IMPA) is an important condition to recognize in dogs. Treatment of IMPA is significantly different than treatment of many other conditions that may present with similar clinical signs, and protocols may vary between patients. Therefore, making an accurate diagnosis is critical. This article identifies some of the key considerations for establishing the diagnosis and making appropriate treatment plans for dogs with IMPA.
Treatment of Pituitary-Dependent Hyperadrenocorticism
Pituitary-dependent hyperadrenocorticism (PDH) is the most common cause of spontaneous Cushing’s syndrome in dogs. It is the result of the inappropriate secretion of adrenocorticotropic hormone (ACTH) by a pituitary adenoma.
Nutrition and Canine Osteoarthritis: What Do We Know?
Can the New Zealand green-lipped mussel be useful in treating dogs suffering with osteoarthritis? The (research) jury is still out. While there is no known cure for degenerative joint disease, there are nutritional approaches that can play an important role in helping your patients with OA.